Kai Huang

机构：Fujian Medical University, The University of Texas at San Antonio Health Science Center, The University of Texas Health Science Center at Houston · ORCID：0000-0002-7683-5093

发表论文 53 篇 · 总被引 986 次 · h-index 16

代表论文

• Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer (2023 · Nature Communications · 被引 252)
• Automated Contouring and Planning in Radiation Therapy: What Is ‘Clinically Acceptable’? (2023 · Diagnostics · 被引 103)
• Neoadjuvant Therapy with Immune Checkpoint Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis (2023 · Annals of Surgical Oncology · 被引 37)
• Deep learning–based automatic segmentation of cardiac substructures for lung cancers (2023 · Radiotherapy and Oncology · 被引 33)
• The efficacy and safety of vonoprazan–amoxicillin dual therapy in eradicating Helicobacter pylori: a systematic review and meta-analysis (2023 · European journal of medical research · 被引 22)
• Comparison of the efficacy and safety between rivaroxaban and dabigatran in the treatment of acute portal vein thrombosis in cirrhosis (2023 · BMC Gastroenterology · 被引 14)